Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
$315.39M
Mr. Thomas Andrew Butler
75.00
Redwood City, CA
Apr 16, 2021
-2.23
$-3.90
4.50
4.62
-2,273.69%
-2.13
0.00
2.86
48.70
4.62
-102.56%
-91.86%
Similar stocks (5)
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Design Therapeutics, Inc.
DSGN
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.05675%
BlackRock Future Health ETF
BMED
0.05601%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.026%
iShares Biotechnology ETF
IBB
0.02002%
iShares Russell 2000 Growth ETF
IWO
0.01662%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.0083%
ProShares Ultra Nasdaq Biotechnology
BIB
0.0078705330777195%
ProShares Ultra Russell2000
UWM
0.003116754683216065%
Schwab U.S. Small-Cap ETF
SCHA
0.003057846%
ProShares UltraPro Russell2000
URTY
0.0015359891488260858%
ProShares Hedge Replication ETF
HDG
0.001311472019632443%
iShares Russell 3000 ETF
IWV
2.8e-4%
Schwab U.S. Broad Market ETF
SCHB
2.10324e-4%
Dimensional US Core Equity Market ETF
DFAU
1.7350999999999998e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.2153000000000001e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (5)
Edgewise Therapeutics, Inc.
EWTX
Cullinan Oncology, Inc.
CGEM
Design Therapeutics, Inc.
DSGN
Werewolf Therapeutics, Inc.
HOWL
Ikena Oncology, Inc.
IKNA
ETF Exposure (29)
iShares Micro-Cap ETF
IWC
0.05675%
BlackRock Future Health ETF
BMED
0.05601%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.026%
iShares Biotechnology ETF
IBB
0.02002%
iShares Russell 2000 Growth ETF
IWO
0.01662%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 ETF
IWM
0.0083%
ProShares Ultra Nasdaq Biotechnology
BIB
0.0078705330777195%
ProShares Ultra Russell2000
UWM
0.003116754683216065%
Schwab U.S. Small-Cap ETF
SCHA
0.003057846%
ProShares UltraPro Russell2000
URTY
0.0015359891488260858%
ProShares Hedge Replication ETF
HDG
0.001311472019632443%
iShares Russell 3000 ETF
IWV
2.8e-4%
Schwab U.S. Broad Market ETF
SCHB
2.10324e-4%
Dimensional US Core Equity Market ETF
DFAU
1.7350999999999998e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.2153000000000001e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%